Investigation of a Ventrodorsal Hippocampal Pathway to Regulate Cognition

por Lodge, Daniel J.
Publicado 2021

O9.5. ABERRANT DOPAMINE SYSTEM FUNCTION REVERSED BY THE OREXIN RECEPTOR ANTAGONIST TCS1102 IN A RODENT MODEL OF SCHIZOPHRENIA

por Perez, Stephanie, Lodge, Daniel
Publicado 2018

Hippocampal interneuron transplants reverse aberrant dopamine system function and behavior in a rodent model of schizophrenia

por Perez, Stephanie M., Lodge, Daniel J.
Publicado 2013

New approaches to the management of schizophrenia: focus on aberrant hippocampal drive of dopamine pathways

por Perez, Stephanie M, Lodge, Daniel J
Publicado 2014

Hippocampal Perineuronal Nets Are Required for the Sustained Antidepressant Effect of Ketamine

por Donegan, Jennifer J, Lodge, Daniel J
Publicado 2016

Orexin Modulation of VTA Dopamine Neuron Activity: Relevance to Schizophrenia

por Perez, Stephanie M, Lodge, Daniel J
Publicado 2021

Increasing Endocannabinoid Levels in the Ventral Pallidum Restore Aberrant Dopamine Neuron Activity in the Subchronic PCP Rodent Model of Schizophrenia

por Aguilar, David D, Chen, Li, Lodge, Daniel J
Publicado 2014

Speaker 4: Alan Frazer, USA

por Frazer, Alan, Carreño, Flavia, Collins, Gregory, Lodge, Daniel
Publicado 2016

Adolescent Synthetic Cannabinoid Exposure Produces Enduring Changes in Dopamine Neuron Activity in a Rodent Model of Schizophrenia Susceptibility

por Aguilar, David D, Giuffrida, Andrea, Lodge, Daniel J
Publicado 2018

Region specific knockdown of Parvalbumin or Somatostatin produces neuronal and behavioral deficits consistent with those observed in schizophrenia

por Perez, Stephanie M., Boley, Angela, Lodge, Daniel J.
Publicado 2019

Increased Presynaptic Dopamine Synthesis Capacity Is Associated With Aberrant Dopamine Neuron Activity in the Methylazoxymethanol Acetate Rodent Model Used to Study Schizophrenia-R...

por Perez, Stephanie M, Elam, Hannah B, Lodge, Daniel J
Publicado 2022

Selective Pharmacological Augmentation of Hippocampal Activity Produces a Sustained Antidepressant-Like Response without Abuse-Related or Psychotomimetic Effects

por Carreno, Flavia R., Collins, Gregory T., Frazer, Alan, Lodge, Daniel J.
Publicado 2017

Gestational Buprenorphine Exposure Disrupts Dopamine Neuron Activity and Related Behaviors in Adulthood

por Elam, Hannah B., Donegan, Jennifer J., Hsieh, Jenny, Lodge, Daniel J.
Publicado 2022

Discrete hippocampal projections are differentially regulated by parvalbumin and somatostatin interneurons

por Lodge, Daniel J., Elam, Hannah B., Boley, Angela M., Donegan, Jennifer J.
Publicado 2023

Orexin receptor antagonists reverse aberrant dopamine neuron activity and related behaviors in a rodent model of stress-induced psychosis

por Elam, Hannah B., Perez, Stephanie M., Donegan, Jennifer J., Lodge, Daniel J.
Publicado 2021

Aberrant Dopamine System Function in the Ferrous Amyloid Buthionine (FAB) Rat Model of Alzheimer’s Disease

por Perez, Stephanie M., Boley, Angela M., McCoy, Alexandra M., Lodge, Daniel J.
Publicado 2023

Selective Deletion of the Leptin Receptor in Dopamine Neurons Produces Anxiogenic-like Behavior and Increases Dopaminergic Activity in Amygdala

por Liu, Jing, Perez, Stephanie M., Zhang, Wei, Lodge, Daniel J., Lu, Xin-Yun
Publicado 2011

Developmental alterations in the transcriptome of three distinct rodent models of schizophrenia

por Donegan, Jennifer J., Boley, Angela M., Glenn, Jeremy P., Carless, Melanie A., Lodge, Daniel J.
Publicado 2020

GL-II-73, a Positive Allosteric Modulator of α5GABA(A) Receptors, Reverses Dopamine System Dysfunction Associated with Pilocarpine-Induced Temporal Lobe Epilepsy

por McCoy, Alexandra M., Prevot, Thomas D., Sharmin, Dishary, Cook, James M., Sibille, Etienne L., Lodge, Daniel J.
Publicado 2023

Stem cell derived interneuron transplants as a treatment for schizophrenia: preclinical validation in a rodent model

por Donegan, Jennifer J., Tyson, Jennifer A., Branch, Sarah Y., Beckstead, Michael J., Anderson, Stewart A., Lodge, Daniel J.
Publicado 2016